Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DB101 vs Humira in Moderate to Severe Plaque Psoriasis
CTR20190112Phase 3Active
- Sponsor
- Tonghua Dongbao
- Start
- Feb 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in plaque psoriasis, sponsored by Tonghua Dongbao. Started Feb 2019; status: active.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20190112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190112.